Should the McGill University Health Center replace the Jelco/Cathlon catheter by the ProtectIVPlus catheter for intravenous infusions?
McGregor M
Record ID 32003000484
English
Authors' objectives:
This study assesses the benefits and costs involved if the four hospitals that make up the McGill University Health Centre (MUHC) should replace the presently used Jelco/Cathlon Needle with a safety device, the ProtectIVPlus. The objective of this device, used only for intravenous infusion lines, is to reduce the risk of needlestick injuries with their associated risk of infection by the Human Immunodeficiency Virus (HIV), Hepatitis C (HC), and Hepatitis B (HB). Such devices now occupy approximately 20 percent of the Canadian market, and their use is mandated throughout the USA.
Authors' recommendations:
The principal benefit that would result from the introduction of the ProtectIVPlus (J&J) safety device for all intravenous infusions carried out at the McGill University Health Center (MUHC) would be relief from fear of infection for approximately 20 individuals per year, and protection of 7 individuals from the need to undergo 28 days prophylactic triple therapy. It would have no easily measurable effect on the risk of infection of health workers. The estimated direct net cost of obtaining these benefits would be approximately $244,000 per year to the Quebec health-care system or $193,000 to the MUHC.
Authors' methods:
Overview
Details
Project Status:
Completed
URL for project:
http://www.mcgill.ca/tau/publications/2002
Year Published:
2002
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Catheterization
- Infusions, Intravenous
- Needlestick Injuries
Contact
Organisation Name:
Technology Assessment Unit of the McGill University Health Centre (MUHC)
Contact Address:
Technology Assessment Unit of the MUHC, Centre for Outcomes Research and Evaluation (CORE), Research Institute of the McGill University Health Centre, 5252 boul. de Maisonneuve, Bureau 3F.50, Montreal, Quebec H4A 3S5
Contact Name:
nandini.dendukuri@mcgill.ca
Contact Email:
nandini.dendukuri@mcgill.ca
Copyright:
Technology Assessment Unit of the McGill University Health Centre (MUHC)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.